{
    "clinical_study": {
        "@rank": "94024", 
        "arm_group": [
            {
                "arm_group_label": "Cetirizine", 
                "arm_group_type": "Active Comparator", 
                "description": "zyrtec 10mg, oral, one time"
            }, 
            {
                "arm_group_label": "Sugar pill", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo, one pill, one time"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is determine if long acting antihistamine like zyrtec can help\n      with itching induced by opioid pain medications."
        }, 
        "brief_title": "Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching", 
        "completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Pruritus", 
        "condition_browse": {
            "mesh_term": "Pruritus"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Children age 6-18yrs on opioids who develop pruritus and are willing to participate\n             in the study\n\n        Exclusion Criteria:\n\n          -  Children with history of chronic urticaria\n\n          -  Children with other chronic pruritic condition like eczema, contact dermatitis,\n             psoriasis\n\n          -  Children with known hypersensitivity to cetirizine\n\n          -  Children on second generation antihistamine 1 week prior to the study recruitment\n\n          -  Children who are unwilling or unable to swallow the capsule\n\n          -  Children with chronic liver or kidney disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "6 Years"
        }, 
        "enrollment": {
            "#text": "73", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01825655", 
            "org_study_id": "IIS2012-003"
        }, 
        "intervention": [
            {
                "arm_group_label": "Cetirizine", 
                "intervention_name": "Cetirizine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Sugar pill", 
                "intervention_name": "Placebo or sugar pill", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Histamine Antagonists", 
                "Cetirizine", 
                "Histamine H1 Antagonists", 
                "Analgesics, Opioid"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 10, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Richmond", 
                    "country": "United States", 
                    "state": "Virginia", 
                    "zip": "23298"
                }, 
                "name": "Children's Hospital of Richmond at VCU"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Long Acting Antihistamine on Opioid- Induced Pruritus: A Double-blind Placebo Controlled Study", 
        "overall_contact": {
            "email": "skumar@vcu.edu", 
            "last_name": "Santhosh Kumar, MD", 
            "phone": "804-628-1605"
        }, 
        "overall_official": {
            "affiliation": "Virginia Commonwealth University", 
            "last_name": "Santhosh Kumar, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Itch score will be used to analyze our primary outcome. The subjects will have an itch score at baseline and compared to itch score at 3hrs post intervention.", 
            "measure": "Itch score", 
            "safety_issue": "No", 
            "time_frame": "3 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01825655"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Virginia Commonwealth University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Virginia Commonwealth University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}